Pharmacokinetic/pharmacodynamic evaluation of the efficacy of flumequine in treating colibacillosis in turkeys

Anadón, 2001, Pharmacokinetics and residues of ciprofloxacin and its metabolites in broiler chickens, Res. Vet. Sci., 71, 101, 10.1053/rvsc.2001.0494 Barnes, 2008, Colibacillosis, 691 Bywater, 2005, Identification and surveillance of antimicrobial resistance dissemination in animal production, Poult. Sci., 84, 644, 10.1093/ps/84.4.644 Charleston, 1998, Comparison of the efficacies of three fluoroquinolone antimicrobial agents, given as continuous or pulsed-water medication, against Escherichia coli infection in chickens, Antimicrob. Agents Chemother., 42, 83, 10.1128/AAC.42.1.83 CLSI (Clinical and Laboratory Standards Institute), 2008 Commission Decision 2002/657/EC. 2002. Implementing Council Directive 96/23/EC Concerning the Performances of Analytical Methods and the Interpretation of Results. Official Journal of the European Communities, No. L221, 17/08/2002, European Commission, Directorate General for Public Health and Consumers Protection. Council of Europe. 2007. Appendix A to the European Conventions for the Protection of Vertebrate Animals used for Experimental and Other Scientific Purposes (ETS No. 123). Guidelines for Accommodation and Care of Animals (Art. 5 of the Convention). Accessed Nov. 2011. http://conventions.coe.int/Treaty/en/Treaties/Html/123.htm#Article5. Dimitrova, 2007, Pharmacokinetics of enrofloxacin in turkeys, Res. Vet. Sci., 82, 392, 10.1016/j.rvsc.2006.09.004 EFSA, 2010, European Food Safety Authority. The Community Summary Report on antimicrobial resistance in zoonotic and indicator bacteria from animals and food in the European Union in 2004–2007, EFSA Journal, 8, 1309 EMA. 2006. The European Agency for Evaluation of Medicinal Products. Reflection paper on the use of fluoroquinolones in food-producing animals in the European union: Development of resistance and impact on human and animal health. EMEA/CVMP/SAGAM/184651/2005. FDA. 2005. U.S. Food and Drug Administration. Withdrawal of approval of the new animal drug application for enrofloxacin in poultry; Docket No. 2000N-1571. Accessed Apr. 18, 2013. http://www.fda.gov/AnimalVeterinary/SafetyHealth/RecallsWithdrawals/ucm042004.htm. Garcés, 2006, Determination of a series of quinolones in pig plasma using solid-phase extraction and liquid chromatography coupled with mass spectrometric detection: Application to pharmacokinetic studies, J. Chromatogr. A., 1137, 22, 10.1016/j.chroma.2006.09.082 Gibaldi, 1982 Haritova, 2006, Pharmacokinetic-pharmacodynamic modelling of danofloxacin in turkeys, Vet. Res. Commun., 30, 775, 10.1007/s11259-006-3400-7 Lam, 1985, Estimation of variance for harmonic mean half-lives, J. Pharm. Sci., 74, 229, 10.1002/jps.2600740229 Löhren, 2008, Guidelines for antimicrobial use in poultry, 126 Martinez, 2006, Pharmacology of the fluoroquinolones: A perspective for the use in domestic animals, Vet. J., 172, 10, 10.1016/j.tvjl.2005.07.010 McKellar, 2004, Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine, J. Vet. Pharmacol. Ther., 27, 503, 10.1111/j.1365-2885.2004.00603.x Mevius, 1990, Pharmacokinetics metabolism and renal clearance of flumequine in veal calves, J. Vet. Pharmacol. Ther., 13, 159, 10.1111/j.1365-2885.1990.tb00764.x Ozawa, 2010, Comparison of in vitro activities and pharmacokinetics/pharmacodynamics estimations of veterinary fluoroquinolones against avian pathogenic Escherichia coli isolates, Microb. Drug Resist., 16, 327, 10.1089/mdr.2010.0024 Papich, 2009, Fluoroquinolone antimicrobial drugs, 983 Russo, 2012, Approved medication of water with enrofloxacin to treat turkey colibacillosis: Assessment of efficacy using a PK/PD approach, Vet. Microbiol., 161, 206, 10.1016/j.vetmic.2012.07.028 Samanidou, 2005, Direct determination of five fluoroquinolones in chicken whole blood and veterinary drugs by HPLC, J. Sep. Sci., 28, 325, 10.1002/jssc.200400042 Sanders, 2001, Mechanisms responsible for cross-resistance and dichotomous resistance among the quinolones, Clin. Infect. Dis., 32, S1, 10.1086/319369 Toutain, 2002, The pharmacokinetic-pharmacodynamic approach to a rational dosage regimen for antibiotics, Res. Vet. Sci., 73, 105, 10.1016/S0034-5288(02)00039-5 Vermeulen, 2002, Drug administration to poultry, Adv. Drug Deliv. Rev., 54, 795, 10.1016/S0169-409X(02)00069-8 VICH GL 49. 2011. (2012-Final), Guidance for Industry, Studies to evaluate the metabolism and residue kinetics of veterinary drugs in food producing animals: Validation of analytical methods used in residue depletion studies, February 2011. Accessed Feb. 2012. http://www.vichsec.org/en/guidelines2.htm. Villa, 2005, Pharmacodynamics and pharmacokinetics of flumequine in pigs after single intravenous and intramuscular administration, Vet. J., 170, 101, 10.1016/j.tvjl.2004.05.012 Walsh, 2008, Antimicrobial resistance in foodborne pathogens—A cause for concern?, Curr. Drug Targets, 9, 808, 10.2174/138945008785747761 Webber, 2001, Quinolone resistance in Escherichia coli, Vet. Res., 32, 275, 10.1051/vetres:2001124 World Health Organization. 2011. World health day 2011. In Urgent Action Necessary to Safeguard Drug Treatments, WHO, Geneva. Accessed Apr. 18, 2013. http://www.who.int/mediacentre/news/releases/2011/whd_20110406/en/index.html. Yamaoka, 1978, Application of Akaike’s information criterion (AIC) in the evaluation of linear pharmacokinetic equations, J. Pharmacokinet. Biopharm., 6, 165, 10.1007/BF01117450